Stevanato Group Reports Third Quarter 2023 Financial Results
- Reiterates Full Year 2023 Guidance - ...
Stay updated with breaking news from Diagnostic Solutions Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Reiterates Full Year 2023 Guidance - ...
- Reiterates Full Year 2023 Revenue and Adjusted Diluted Earnings per Share Guidance; Increases Adjusted EBITDA Guidance - ...
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology
- Reiterates Full Year 2023 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced